Talphera, Inc. Reports Q1 2025 Results, Private Placement
Ticker: TLPH · Form: 10-Q · Filed: May 14, 2025 · CIK: 1427925
| Field | Detail |
|---|---|
| Company | Talphera, Inc. (TLPH) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, private-placement, warrants, pharmaceuticals
TL;DR
Talphera closed Q1 2025 with a private placement and warrant issuance on April 2nd. $
AI Summary
Talphera, Inc. (formerly AcelRx Pharmaceuticals Inc.) filed a 10-Q for the period ending March 31, 2025. The company reported on its financial activities, including a March 2025 private placement with multiple closings and the issuance of prefunded warrants on April 2, 2025. Specific dollar amounts and details of these transactions are available within the filing.
Why It Matters
This filing provides insight into Talphera's financial health and recent capital-raising activities, which can impact its ability to fund operations and future growth.
Risk Assessment
Risk Level: medium — The company has undergone a name change and is involved in private placements and warrant issuances, indicating potential financial restructuring or funding needs.
Key Numbers
- 20250331 — Period End Date (The financial reporting period covered by this 10-Q.)
- 20250514 — Filing Date (The date this 10-Q was officially filed with the SEC.)
Key Players & Entities
- TALPHERA, INC. (company) — Filer
- ACELRX PHARMACEUTICALS INC (company) — Former company name
- 20250331 (date) — Period of report
- 20250514 (date) — Filing date
- 2025-01-01 (date) — Quarter start date
- 2025-04-02 (date) — Date of prefunded warrants issuance
FAQ
What was the primary purpose of the March 2025 private placement?
The filing indicates a March 2025 Private Placement occurred, but the specific purpose is not detailed in the provided snippet.
When were the prefunded warrants issued?
The prefunded warrants were issued as part of a subsequent event on April 2, 2025.
What is Talphera, Inc.'s former name?
Talphera, Inc.'s former name was ACELRX PHARMACEUTICALS INC.
What is the company's primary industry?
The company is in the Pharmaceutical Preparations industry (SIC code 2834).
What is the fiscal year end for Talphera, Inc.?
The fiscal year end for Talphera, Inc. is December 31st.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding TALPHERA, INC. (TLPH).